Management of Amavata (Rheumatoid arthritis) with herbo-mineral formulation -A clinical study
DOI:
https://doi.org/10.47552/ijam.v1i3.27Keywords:
Rheumatoid Arthritis, Amavata, Herbo-mineral drugs, AyurvedaAbstract
Rheumatoid Arthritis (R.A) is a chronic, progressive and disabling auto-immune disease that causes chronic inflammation of the joints. It makes life miserable and crippling due to unknown cause, claiming the maximum loss of human working capacity. The polyarticular joint disease has been described in Ayurveda has high resemblance with Rheumatoid arthritis in modern medicine. The disease draws attention for the consideration of research firstly due to the gravity of the problem and secondly due to lack of adverse free modern drugs for the treatment of R.A. Hence the present study has been taken up to see the efficacy of a combination of herbomineral drugs i.e Sunthi, Guggulu and Godanthi bhasma (1:2:1 ratio) on 71 cases of Amavata (R.A). The study observations showed that the overall treatment response among the cases studied, 10 (15%) cases showed good response, 20 (30%) cases showed fair response, 33 (49%) cases showed mild response and 4 (06%) patients did not show any response and rest 4 cases were dropouts. There was a significant improvement in loss of appetite, anorexia, fever in amavata patients after treatment. Statistical analysis of the mean difference before and after treatment in relief on all the above symptoms except in sub cutaneous nodules and erythrocyte sedimentation rate (ESR), were found highly significant (P<0.0001). It was also observed a definite improvement and subjectively maximum patients had a feeling of well-being. No side effects were reported during and after the treatment.
Published
How to Cite
Issue
Section
License
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.